AMARIN CORP PLC\UK

AMRN ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $213.6M $228.6M $306.9M $369.2M $583.2M $614.1M $429.8M $229.2M
Cost of Revenue $121.3M $131.4M $96.0M $54.5M
Gross Profit $120.9M $81.4M $165.5M $242.5M $461.9M $482.6M $333.7M $174.7M
Gross Margin 56.6% 35.6% 53.9% 65.7% 79.2% 78.6% 77.7% 76.2%
Operating Expenses
Research & Development $19.8M $20.9M $22.2M $30.4M $29.3M $39.0M $34.4M $55.9M
SG&A Expense $115.0M $152.3M $199.9M $304.4M $408.3M $463.3M $323.6M $227.0M
Operating Income $-50.2M $-91.8M $-67.6M $-105.9M $10.5M $-19.7M $-24.3M $-108.2M
Operating Margin -23.5% -40.2% -22.0% -28.7% 1.8% -3.2% -5.6% -47.2%
Interest Expense $7.0K $7.0K $8.0K $15.0K $129.0K $2.6M $6.6M $8.9M
Pretax Income $-36.0M $-77.2M $-53.7M $-103.8M $11.3M $-17.3M $-22.5M $-116.3M
Income Tax Expense $2.8M $5.0M $5.4M $2.0M $3.6M $745.0K $164.0K $96.0K
Net Income $-38.8M $-82.2M $-59.1M $-105.8M $7.7M $-18.0M $-22.6M $-116.4M
Net Margin -18.2% -35.9% -19.3% -28.7% 1.3% -2.9% -5.3% -50.8%
EPS (Basic) $-0.09 $-0.20 $-0.15 $-0.26 $0.02 $-0.05 $-0.07 $-0.39
EPS (Diluted) $-0.09 $-0.20 $-0.15 $-0.26 $0.02 $-0.05 $-0.07 $-0.39
Shares Outstanding (Basic) 415.0M 410.9M 407.7M 401.2M 396.0M 381.8M 342.5M 297.2M
Shares Outstanding (Diluted) 415.0M 410.9M 407.7M 401.2M 402.5M 381.8M 342.5M 297.2M
Dividends Per Share
← Newer Page 1 of 3 Older →